Iodine-131 tositumomab promising in refractory NHL

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1312, 2001-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Iodine-131 tositumomab after CHOP promising for follicular NHL

Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Iodine-131 tositumomab/tositumomab: First reports of anaphylaxis and motor sensory axonal neuropathy: case report

Reactions Weekly, Vol. 1, Iss. 1351, 2011-01 ,pp. : 28-28

Adis International

Access to resources Recommend Favorite

Tositumomab/iodine-131 tositumomab: Acute myeloid leukaemia (first report) and myelodysplastic syndromes: 4 case reports

Reactions Weekly, Vol. 1, Iss. 1174, 2007-01 ,pp. : 25-26

Adis International

Access to resources Recommend Favorite

Iodine-131 tositumomab [Bexxar] is effective in B-cell lymphoma that has progressed after rituximab therapy

Inpharma, Vol. 1, Iss. 1482, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Bendamustine brings hope in refractory NHL

Inpharma, Vol. 1, Iss. 1523, 2006-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite